Lisinopril Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg
Reference Brands: Prinivil, Zestril(US & EU)
Category:
Medical Aid
Lisinopril tablets are ACE inhibitors that block the conversion of angiotensin I to angiotensin II, a vasoconstrictor. Benefits include lowering blood pressure, reducing the risk of strokes and heart attacks, and treating heart failure. They improve cardiovascular health, ease workload on the heart, and protect kidney function.
Lisinopril Tablets is available in Tablet
and strengths such as 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lisinopril Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lisinopril Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Lisinopril tablets are approved in both the US and EU, supported by comprehensive dossiers demonstrating safety, efficacy, and quality compliance with GMP standards. In the US, regulations are overseen by the FDA, while in the EU, EMA manages approval processes. These dossiers include clinical trial data, stability, manufacturing practices, and safety profiles. Lisinopril is widely prescribed for hypertension, heart failure, and kidney protection, with market authorization granted after rigorous evaluation. For detailed licensing, approved dossiers, and regulatory updates in global markets, visit Pharmatradz. Stay informed on the latest regulatory requirements for lisinopril and ensure compliance for market success.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing